DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
1.900
-0.010 (-0.52%)
At close: Aug 13, 2025, 4:00 PM
1.870
-0.030 (-1.58%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
DURECT Employees
DURECT had 21 employees as of December 31, 2024. The number of employees decreased by 37 or -63.79% compared to the previous year.
Employees
21
Change (1Y)
-37
Growth (1Y)
-63.79%
Revenue / Employee
$78,905
Profits / Employee
-$165,619
Market Cap
58.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DRRX News
- 1 day ago - DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - PRNewsWire
- 15 days ago - Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - Benzinga
- 16 days ago - Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - Accesswire
- 3 months ago - DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 5 months ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 5 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire
- 6 months ago - DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire